These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 34693748)

  • 21. Partially clustered designs for clinical trials: Unifying existing designs using consistent terminology.
    Lange KM; Kasza J; Sullivan TR; Yelland LN
    Clin Trials; 2023 Apr; 20(2):99-110. PubMed ID: 36628406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A general method for calculating power for GEE analysis of complete and incomplete stepped wedge cluster randomized trials.
    Zhang Y; Preisser JS; Turner EL; Rathouz PJ; Toles M; Li F
    Stat Methods Med Res; 2023 Jan; 32(1):71-87. PubMed ID: 36253078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sample size estimation for modified Poisson analysis of cluster randomized trials with a binary outcome.
    Li F; Tong G
    Stat Methods Med Res; 2021 May; 30(5):1288-1305. PubMed ID: 33826454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contamination: How much can an individually randomized trial tolerate?
    Hemming K; Taljaard M; Moerbeek M; Forbes A
    Stat Med; 2021 Jun; 40(14):3329-3351. PubMed ID: 33960514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Power analysis for cluster randomized trials with continuous coprimary endpoints.
    Yang S; Moerbeek M; Taljaard M; Li F
    Biometrics; 2023 Jun; 79(2):1293-1305. PubMed ID: 35531926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BASIC: A Bayesian adaptive synthetic-control design for phase II clinical trials.
    Jiang L; Thall PF; Yan F; Kopetz S; Yuan Y
    Clin Trials; 2023 Oct; 20(5):486-496. PubMed ID: 37313712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generalized estimating equations in cluster randomized trials with a small number of clusters: Review of practice and simulation study.
    Huang S; Fiero MH; Bell ML
    Clin Trials; 2016 Aug; 13(4):445-9. PubMed ID: 27094487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating the performance of Bayesian and restricted maximum likelihood estimation for stepped wedge cluster randomized trials with a small number of clusters.
    Grantham KL; Kasza J; Heritier S; Carlin JB; Forbes AB
    BMC Med Res Methodol; 2022 Apr; 22(1):112. PubMed ID: 35418034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sample size calculation in three-level cluster randomized trials using generalized estimating equation models.
    Liu J; Colditz GA
    Stat Med; 2020 Oct; 39(24):3347-3372. PubMed ID: 32720717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal design of cluster randomized trials allowing unequal allocation of clusters and unequal cluster size between arms.
    Copas AJ; Hooper R
    Stat Med; 2021 Nov; 40(25):5474-5486. PubMed ID: 34312902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imputing intracluster correlation coefficients from a posterior predictive distribution is a feasible method of dealing with unit of analysis errors in a meta-analysis of cluster RCTs.
    Konnyu KJ; Taljaard M; Ivers NM; Moher D; Grimshaw JM
    J Clin Epidemiol; 2021 Nov; 139():307-318. PubMed ID: 34171503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bayesian optimal stepped wedge design.
    Singh SP
    Biom J; 2024 Jan; 66(1):e2300168. PubMed ID: 38057145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Explaining the variation in the attained power of a stepped-wedge trial with unequal cluster sizes.
    Ouyang Y; Karim ME; Gustafson P; Field TS; Wong H
    BMC Med Res Methodol; 2020 Jun; 20(1):166. PubMed ID: 32580698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and analysis of a 2-year parallel follow-up of repeated ivermectin mass drug administrations for control of malaria: Small sample considerations for cluster-randomized trials with count data.
    Jackson CL; Colborn K; Gao D; Rao S; Slater HC; Parikh S; Foy BD; Kittelson J
    Clin Trials; 2021 Oct; 18(5):582-593. PubMed ID: 34218684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A practical Bayesian stepped wedge design for community-based cluster-randomized clinical trials: The British Columbia Telehealth Trial.
    Cunanan KM; Carlin BP; Peterson KA
    Clin Trials; 2016 Dec; 13(6):641-650. PubMed ID: 27430710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomizing patients by family practice: sample size estimation, intracluster correlation and data analysis.
    Cosby RH; Howard M; Kaczorowski J; Willan AR; Sellors JW
    Fam Pract; 2003 Feb; 20(1):77-82. PubMed ID: 12509376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraclass correlation coefficients for cluster randomized trials in primary care: data from the MRC Trial of the Assessment and Management of Older People in the Community.
    Smeeth L; Ng ES
    Control Clin Trials; 2002 Aug; 23(4):409-21. PubMed ID: 12161083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient design of cluster randomized and multicentre trials with unknown intraclass correlation.
    van Breukelen GJ; Candel MJ
    Stat Methods Med Res; 2015 Oct; 24(5):540-56. PubMed ID: 21937473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unifying the analysis of continuous and categorical measures of weight loss and incorporating group effect: a secondary re-analysis of a large cluster randomized clinical trial using Bayesian approach.
    Tang F; Befort CA; Wick J; Gajewski BJ
    BMC Med Res Methodol; 2022 Jan; 22(1):28. PubMed ID: 35081912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.